Koers Acerus Pharmaceuticals Corporation Toronto S.E.
Aandelen
ASP
CA00444G4051
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01-05-18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09-09-13 |
Borys Chabursky
BRD | Director/Board Member | - | 20-12-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,89% | 705 mld. | |
+32,82% | 583 mld. | |
-3,63% | 364 mld. | |
+20,19% | 332 mld. | |
+5,08% | 291 mld. | |
+16,64% | 238 mld. | |
-4,13% | 210 mld. | |
+10,63% | 209 mld. | |
+8,68% | 169 mld. |